Patriot Investment Management Inc. Gilead Sciences, Inc. Transaction History

Patriot Investment Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $334,858 - $381,555	-5,911 Closed	0 $0
Q3 2020 Oct 23, 2020	SELL	$62.1 - $78.08 $117,244 - $147,415	-1,888 Reduced 24.21%	5,911 $373,000
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $108,365 - $125,832	1,498 Added 23.77%	7,799 $600,000
Q1 2020 May 06, 2020	BUY	$62.63 - $80.22 $394,631 - $505,466	6,301 New	6,301 $471,000

1,925

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Patriot Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Patriot Investment Management Inc. with notifications on news.